In early 2006, the positive results of a small preliminary trial on Diatroxal® convinced us to invest in a larger Phase 1, Randomized, Double-Blind, Placebo Controlled, Human Clinical Study.

The study was designed primarily to examine how well Diatroxal® works with the body to promote healthy blood sugar by measuring response in a glucose challenge test, A1c, and other biological markers.

Secondarily, the study examined how well Diatroxal® works with the body to promote healthy triglyceride, cholesterol, and blood pressure health. The study began in June 2007 and concluded in September 2007.

The study also measured 14, 30, 60, and 90 day fasting blood sugar levels. The 90 day reading supplied A1c levels that were compared to those taken at the start of the study.

The final study results are so positive that they are hard to believe!

We invite you to review the complete Diatroxal® clinical trial report and peer review.